EMD-28540

Single-particle
3.7 Å
EMD-28540
3D View Gallery
Deposition: 08/10/2022
Map released: 19/04/2023
Last modified: 19/06/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-28540

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8eqn summary report (pdf.gz) Map-8eqn FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

BG505 UFO-E2p-L4P nanoparticle reconstructed by focused refinement with a mask around the nanoparticle core

EMD-28540

Single-particle
3.7 Å
EMD-28540
3D View Gallery
Deposition: 08/10/2022
Map released: 19/04/2023
Last modified: 19/06/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human immunodeficiency virus 1
Sample: BG505 UFO-E2p-L4P nanoparticle reconstructed by focused refinement with a mask around the nanoparticle core
Fitted models: 8eqn

Deposition Authors: Antanasijevic A, Zhang YN , Zhu J , Ward AB
Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimmers as HIV-1 vaccine candidates.
Zhang YN , Paynter J, Antanasijevic A, Allen JD , Eldad M , Lee YZ , Copps J , Newby ML, He L, Chavez D, Frost P, Goodroe A, Dutton J, Lanford R, Chen C, Wilson IA , Crispin M , Ward AB , Zhu J
(2023) Nat Commun , 14 , 1985 - 1985
PUBMED: 37031217
DOI: doi:10.1038/s41467-023-37742-z
ISSN: 2041-1723
Grant Support: